How much profit has Bioton made this year?
Bioton has made 2.28 M PLN this year.
Bioton Net Income 2024
Bioton Net Income
2.28 M PLN
Ticker
BIO.WA
ISIN
PLBIOTN00029
WKN
A0D9SD
In 2024, Bioton's profit amounted to 2.28 M PLN, a 60.1% increase from the 1.42 M PLN profit recorded in the previous year.
The Bioton Net Income history
| YEAR | NET INCOME (undefined PLN) |
|---|---|
| 2023 | 2.28 |
| 2022 | 1.42 |
| 2021 | 2.88 |
| 2020 | 33.92 |
| 2019 | -126.69 |
| 2018 | 26.27 |
| 2017 | -20.13 |
| 2016 | -28.57 |
| 2015 | -522.86 |
| 2014 | 3.68 |
| 2013 | -6.4 |
| 2012 | 37.8 |
| 2011 | -78.9 |
| 2010 | 117.2 |
| 2009 | -546.7 |
| 2008 | -218.9 |
| 2007 | 28.2 |
| 2006 | 93.8 |
| 2005 | 19.4 |
| 2004 | 5.8 |
Bioton Revenue, EBIT, Net Income PLBIOTN00029 · A0D9SD
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Bioton, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Bioton from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Bioton’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Bioton. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Bioton’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Bioton’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Bioton’s growth potential.
Bioton Revenue, EBIT and net profit per share
| Date | Bioton Revenue | Bioton EBIT | Bioton Net Income |
|---|---|---|---|
| 2023 | 181.64 M PLN | 13.81 M PLN | 2.28 M PLN |
| 2022 | 233.16 M PLN | 27.93 M PLN | 1.42 M PLN |
| 2021 | 163.03 M PLN | 15.96 M PLN | 2.88 M PLN |
| 2020 | 221.79 M PLN | 30.24 M PLN | 33.92 M PLN |
| 2019 | 202.03 M PLN | -71.22 M PLN | -126.69 M PLN |
| 2018 | 241.17 M PLN | -50.52 M PLN | 26.27 M PLN |
| 2017 | 361.65 M PLN | 2.75 M PLN | -20.13 M PLN |
| 2016 | 277.61 M PLN | -10.83 M PLN | -28.57 M PLN |
| 2015 | 332.56 M PLN | 11.96 M PLN | -522.86 M PLN |
| 2014 | 377.3 M PLN | 21.77 M PLN | 3.68 M PLN |
| 2013 | 340.4 M PLN | 8.8 M PLN | -6.4 M PLN |
| 2012 | 406.3 M PLN | 66.5 M PLN | 37.8 M PLN |
| 2011 | 289 M PLN | -54.6 M PLN | -78.9 M PLN |
| 2010 | 378.6 M PLN | 48 M PLN | 117.2 M PLN |
| 2009 | 286.2 M PLN | -320.4 M PLN | -546.7 M PLN |
| 2008 | 293.5 M PLN | -32.1 M PLN | -218.9 M PLN |
| 2007 | 270.9 M PLN | 100.7 M PLN | 28.2 M PLN |
| 2006 | 215.5 M PLN | 74.9 M PLN | 93.8 M PLN |
| 2005 | 151.6 M PLN | 26.2 M PLN | 19.4 M PLN |
| 2004 | 128.8 M PLN | 16.7 M PLN | 5.8 M PLN |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 128.8 M PLN | 16.7 M PLN | 5.8 M PLN |
| 2005 | 151.6 M PLN | 26.2 M PLN | 19.4 M PLN |
| 2006 | 215.5 M PLN | 74.9 M PLN | 93.8 M PLN |
| 2007 | 270.9 M PLN | 100.7 M PLN | 28.2 M PLN |
| 2008 | 293.5 M PLN | -32.1 M PLN | -218.9 M PLN |
| 2009 | 286.2 M PLN | -320.4 M PLN | -546.7 M PLN |
| 2010 | 378.6 M PLN | 48 M PLN | 117.2 M PLN |
| 2011 | 289 M PLN | -54.6 M PLN | -78.9 M PLN |
| 2012 | 406.3 M PLN | 66.5 M PLN | 37.8 M PLN |
| 2013 | 340.4 M PLN | 8.8 M PLN | -6.4 M PLN |
| 2014 | 377.3 M PLN | 21.77 M PLN | 3.68 M PLN |
| 2015 | 332.56 M PLN | 11.96 M PLN | -522.86 M PLN |
| 2016 | 277.61 M PLN | -10.83 M PLN | -28.57 M PLN |
| 2017 | 361.65 M PLN | 2.75 M PLN | -20.13 M PLN |
| 2018 | 241.17 M PLN | -50.52 M PLN | 26.27 M PLN |
| 2019 | 202.03 M PLN | -71.22 M PLN | -126.69 M PLN |
| 2020 | 221.79 M PLN | 30.24 M PLN | 33.92 M PLN |
| 2021 | 163.03 M PLN | 15.96 M PLN | 2.88 M PLN |
| 2022 | 233.16 M PLN | 27.93 M PLN | 1.42 M PLN |
| 2023 | 181.64 M PLN | 13.81 M PLN | 2.28 M PLN |
Bioton stock margins PLBIOTN00029 · A0D9SD
The Bioton margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bioton. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bioton.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Bioton's sales revenue. A higher gross margin percentage indicates that the Bioton retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Bioton's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Bioton's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Bioton's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Bioton. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Bioton's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Bioton Margin History
| Bioton Gross margin | Bioton Profit margin | Bioton EBIT margin | Bioton Profit margin |
|---|---|---|---|
| 2023 | 40.11 % | 7.61 % | 1.25 % |
| 2022 | 41.07 % | 11.98 % | 0.61 % |
| 2021 | 48.06 % | 9.79 % | 1.77 % |
| 2020 | 47.24 % | 13.63 % | 15.29 % |
| 2019 | 50.65 % | -35.25 % | -62.71 % |
| 2018 | 48.15 % | -20.95 % | 10.89 % |
| 2017 | 51.51 % | 0.76 % | -5.57 % |
| 2016 | 49.72 % | -3.9 % | -10.29 % |
| 2015 | 48.12 % | 3.6 % | -157.22 % |
| 2014 | 41.96 % | 5.77 % | 0.97 % |
| 2013 | 42.83 % | 2.59 % | -1.88 % |
| 2012 | 52.55 % | 16.37 % | 9.3 % |
| 2011 | 35.5 % | -18.89 % | -27.3 % |
| 2010 | 56.13 % | 12.68 % | 30.96 % |
| 2009 | 38.89 % | -111.95 % | -191.02 % |
| 2008 | 43.99 % | -10.94 % | -74.58 % |
| 2007 | 54.63 % | 37.17 % | 10.41 % |
| 2006 | 62.09 % | 34.76 % | 43.53 % |
| 2005 | 70.91 % | 17.28 % | 12.8 % |
| 2004 | 45.73 % | 12.97 % | 4.5 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 45.73 % | 12.97 % | 4.5 % |
| 2005 | 70.91 % | 17.28 % | 12.8 % |
| 2006 | 62.09 % | 34.76 % | 43.53 % |
| 2007 | 54.63 % | 37.17 % | 10.41 % |
| 2008 | 43.99 % | -10.94 % | -74.58 % |
| 2009 | 38.89 % | -111.95 % | -191.02 % |
| 2010 | 56.13 % | 12.68 % | 30.96 % |
| 2011 | 35.5 % | -18.89 % | -27.3 % |
| 2012 | 52.55 % | 16.37 % | 9.3 % |
| 2013 | 42.83 % | 2.59 % | -1.88 % |
| 2014 | 41.96 % | 5.77 % | 0.97 % |
| 2015 | 48.12 % | 3.6 % | -157.22 % |
| 2016 | 49.72 % | -3.9 % | -10.29 % |
| 2017 | 51.51 % | 0.76 % | -5.57 % |
| 2018 | 48.15 % | -20.95 % | 10.89 % |
| 2019 | 50.65 % | -35.25 % | -62.71 % |
| 2020 | 47.24 % | 13.63 % | 15.29 % |
| 2021 | 48.06 % | 9.79 % | 1.77 % |
| 2022 | 41.07 % | 11.98 % | 0.61 % |
| 2023 | 40.11 % | 7.61 % | 1.25 % |
Bioton Aktienanalyse
What does Bioton do?
Bioton SA is a leading Polish biotechnology company specializing in the development of innovative drugs, diagnostics, and medical devices. The company was founded in 1989 and has since achieved remarkable success. Bioton is headquartered in Poland and employs approximately 1000 people worldwide. The company is listed on the Warsaw Stock Exchange and is supported by renowned investors. Business model Bioton operates various business divisions, including research and development, production, sales, as well as marketing and distribution. The company collaborates closely with leading academic institutions and research organizations and invests significant resources in the development of new groundbreaking technologies and products. The company's products and services are distributed and used in over 60 countries worldwide. Divisions Bioton is divided into three main business sectors, including biopharmaceuticals, diagnostics, and medical devices. Biopharmaceuticals Bioton is known for its biopharmaceuticals, particularly insulin and insulin analogs. Insulin is a hormone produced by the body to regulate blood sugar levels. Bioton offers various insulin products, including human insulin, insulin glargine, and insulin aspart. These products are approved for the treatment of diabetes mellitus and are distributed in over 50 countries worldwide. Diagnostics Bioton is also involved in the development and production of diagnostics. The company offers various testing systems for the diagnosis of infectious diseases, allergies, and autoimmune diseases. The product line also includes in vitro diagnostics that are used for medical therapy monitoring and disease detection. Medical devices Bioton also manufactures and distributes medical devices such as insulin pumps and blood glucose meters. These devices are designed for people with diabetes and assist in accurate insulin dosing and blood sugar level monitoring. Products In addition to insulin and insulin analogs, Bioton also produces a wide range of other drugs, including growth hormones, as well as follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones are used for the treatment of infertility. Bioton is also involved in the development of novel technologies such as RNA interference (RNAi) and genomic research. The company invests significantly in innovative research projects aimed at the development of groundbreaking drugs and therapies. In conclusion, Bioton SA is a highly innovative biotechnology company with a wide range of products and a focus on research and development. The company operates in the global market and collaborates closely with renowned institutions and research organizations. Bioton's business model is based on the development of innovative technologies and products aimed at improving the quality of life for people worldwide. Bioton ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Bioton's Profit Margins
The profit margins of Bioton represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Bioton's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Bioton's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Bioton's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Bioton’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Bioton stock
How has the profit developed compared to last year?
The profit has increased by 60.1% compared to last year increased
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Bioton publish its earnings?
Bioton publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Bioton?
The profits of Bioton are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Bioton?
You can learn more about the earnings of Bioton by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Bioton pay?
Over the past 12 months, Bioton paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bioton is expected to pay a dividend of 0 PLN.
What is the dividend yield of Bioton?
The current dividend yield of Bioton is .
When does Bioton pay dividends?
Bioton pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Bioton?
Bioton paid dividends every year for the past 0 years.
What is the dividend of Bioton?
For the upcoming 12 months, dividends amounting to 0 PLN are expected. This corresponds to a dividend yield of 0 %.
In which sector is Bioton located?
Bioton is assigned to the 'Health' sector.
Wann musste ich die Aktien von Bioton kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Bioton from 10/21/2024 amounting to 0 PLN, you needed to have the stock in your portfolio before the ex-date on 10/21/2024.
When did Bioton pay the last dividend?
The last dividend was paid out on 10/21/2024.
What was the dividend of Bioton in the year 2023?
In the year 2023, Bioton distributed 0 PLN as dividends.
In which currency does Bioton pay out the dividend?
The dividends of Bioton are distributed in PLN.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Bioton
Our stock analysis for Bioton Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bioton Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
